Your browser doesn't support javascript.
loading
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia.
Kan, Winnie L; Dhagat, Urmi; Kaufmann, Kerstin B; Hercus, Timothy R; Nero, Tracy L; Zeng, Andy G X; Toubia, John; Barry, Emma F; Broughton, Sophie E; Gomez, Guillermo A; Benard, Brooks A; Dottore, Mara; Cheung Tung Shing, Karen S; Boutzen, Héléna; Samaraweera, Saumya E; Simpson, Kaylene J; Jin, Liqing; Goodall, Gregory J; Begley, C Glenn; Thomas, Daniel; Ekert, Paul G; Tvorogov, Denis; D'Andrea, Richard J; Dick, John E; Parker, Michael W; Lopez, Angel F.
Afiliação
  • Kan WL; Cytokine Receptor Laboratory, Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Dhagat U; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
  • Kaufmann KB; Department of Biochemistry and Pharmacology and the Australian Cancer Research Foundation Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Hercus TR; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Nero TL; Cytokine Receptor Laboratory, Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Zeng AGX; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
  • Toubia J; Department of Biochemistry and Pharmacology and the Australian Cancer Research Foundation Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Barry EF; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Broughton SE; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Gomez GA; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Benard BA; Cytokine Receptor Laboratory, Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Dottore M; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
  • Cheung Tung Shing KS; Department of Biochemistry and Pharmacology and the Australian Cancer Research Foundation Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Boutzen H; Cytokine Receptor Laboratory, Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Samaraweera SE; Division of Hematology, Department of Medicine, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.
  • Simpson KJ; Cytokine Receptor Laboratory, Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Jin L; Australian Cancer Research Foundation Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
  • Goodall GJ; Department of Biochemistry and Pharmacology and the Australian Cancer Research Foundation Facility for Innovative Cancer Drug Discovery, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Begley CG; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Thomas D; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Ekert PG; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Tvorogov D; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • D'Andrea RJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Dick JE; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
  • Parker MW; Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
  • Lopez AF; Begley Biotech Consulting, Wallington, Victoria, Australia.
Cancer Discov ; 13(8): 1922-1947, 2023 08 04.
Article em En | MEDLINE | ID: mdl-37191437

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptores de Citocinas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptores de Citocinas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália